...
search icon
vtrs-img

Viatris Inc, Common Stock

VTRS

NSQ

$8.48

-$0.11

(-1.28%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$9.89B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
12.42M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
5.59%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.89
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$6.85 L
$13.38 H
$8.48

About Viatris Inc, Common Stock

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. The company sells its products under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. It has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameVTRSSectorS&P500
1-Week Return1.68%-3.69%1.67%
1-Month Return11.43%-0.25%11.74%
3-Month Return-22.2%-8.82%-7.11%
6-Month Return-26.96%-9.39%-4.66%
1-Year Return-28.26%-5.13%9.11%
3-Year Return-14.77%3.36%37%
5-Year Return-49.7%35.62%98.26%
10-Year Return-88.06%86.46%171.67%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue11.95B17.89B16.26B15.43B14.74B[{"date":"2020-12-31","value":66.79,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":90.92,"profit":true},{"date":"2023-12-31","value":86.25,"profit":true},{"date":"2024-12-31","value":82.41,"profit":true}]
Cost of Revenue8.15B12.31B9.77B8.99B9.12B[{"date":"2020-12-31","value":66.2,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":79.33,"profit":true},{"date":"2023-12-31","value":73.01,"profit":true},{"date":"2024-12-31","value":74.05,"profit":true}]
Gross Profit3.80B5.58B6.50B6.44B5.62B[{"date":"2020-12-31","value":58.44,"profit":true},{"date":"2021-12-31","value":85.82,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":99.1,"profit":true},{"date":"2024-12-31","value":86.56,"profit":true}]
Gross Margin31.78%31.17%39.95%41.74%38.15%[{"date":"2020-12-31","value":76.15,"profit":true},{"date":"2021-12-31","value":74.69,"profit":true},{"date":"2022-12-31","value":95.72,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":91.42,"profit":true}]
Operating Expenses3.86B5.21B4.84B5.67B5.61B[{"date":"2020-12-31","value":68,"profit":true},{"date":"2021-12-31","value":91.85,"profit":true},{"date":"2022-12-31","value":85.35,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":98.96,"profit":true}]
Operating Income(210.80M)(34.00M)1.61B766.20M10.10M[{"date":"2020-12-31","value":-13.05,"profit":false},{"date":"2021-12-31","value":-2.11,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":47.45,"profit":true},{"date":"2024-12-31","value":0.63,"profit":true}]
Total Non-Operating Income/Expense(1.01B)(1.27B)605.90M(1.14B)(1.18B)[{"date":"2020-12-31","value":-166.4,"profit":false},{"date":"2021-12-31","value":-209.04,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-188.58,"profit":false},{"date":"2024-12-31","value":-195.3,"profit":false}]
Pre-Tax Income(721.20M)(664.40M)2.81B202.90M(623.20M)[{"date":"2020-12-31","value":-25.64,"profit":false},{"date":"2021-12-31","value":-23.62,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":7.21,"profit":true},{"date":"2024-12-31","value":-22.15,"profit":false}]
Income Taxes(51.30M)604.70M734.60M148.20M11.00M[{"date":"2020-12-31","value":-6.98,"profit":false},{"date":"2021-12-31","value":82.32,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":20.17,"profit":true},{"date":"2024-12-31","value":1.5,"profit":true}]
Income After Taxes(669.90M)(1.27B)2.08B54.70M(634.20M)[{"date":"2020-12-31","value":-32.23,"profit":false},{"date":"2021-12-31","value":-61.06,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":2.63,"profit":true},{"date":"2024-12-31","value":-30.51,"profit":false}]
Income From Continuous Operations(669.90M)(1.27B)2.08B1.83B(634.20M)[{"date":"2020-12-31","value":-32.23,"profit":false},{"date":"2021-12-31","value":-61.06,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":88.11,"profit":true},{"date":"2024-12-31","value":-30.51,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(669.90M)(1.27B)2.08B54.70M(634.20M)[{"date":"2020-12-31","value":-32.23,"profit":false},{"date":"2021-12-31","value":-61.06,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":2.63,"profit":true},{"date":"2024-12-31","value":-30.51,"profit":false}]
EPS (Diluted)4.403.693.352.932.65[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":83.86,"profit":true},{"date":"2022-12-31","value":76.14,"profit":true},{"date":"2023-12-31","value":66.59,"profit":true},{"date":"2024-12-31","value":60.23,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

VTRS
Cash Ratio 0.19
Current Ratio 1.65
Quick Ratio 0.98

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

VTRS
ROA (LTM) 2.49%
ROE (LTM) -3.24%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

VTRS
Debt Ratio Lower is generally better. Negative is bad. 0.55
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.45

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

VTRS
Trailing PE NM
Forward PE 4.02
P/S (TTM) 0.69
P/B 0.55
Price/FCF 31
EV/R 1.59
EV/Ebitda 8.32
PEG 0.14

FAQs

What is Viatris Inc share price today?

Viatris Inc (VTRS) share price today is $8.48

Can Indians buy Viatris Inc shares?

Yes, Indians can buy shares of Viatris Inc (VTRS) on Vested. To buy Viatris Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VTRS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Viatris Inc be purchased?

Yes, you can purchase fractional shares of Viatris Inc (VTRS) via the Vested app. You can start investing in Viatris Inc (VTRS) with a minimum investment of $1.

How to invest in Viatris Inc shares from India?

You can invest in shares of Viatris Inc (VTRS) via Vested in three simple steps:

  • Click on Sign Up or Invest in VTRS stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Viatris Inc shares
What is Viatris Inc 52-week high and low stock price?

The 52-week high price of Viatris Inc (VTRS) is $13.38. The 52-week low price of Viatris Inc (VTRS) is $6.85.

What is Viatris Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Viatris Inc (VTRS) is 0.55

What is Viatris Inc dividend yield?

The dividend yield of Viatris Inc (VTRS) is 5.59%

What is the Market Cap of Viatris Inc?

The market capitalization of Viatris Inc (VTRS) is $9.89B

What is Viatris Inc’s stock symbol?

The stock symbol (or ticker) of Viatris Inc is VTRS

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top